More Problems With the Pfizer-BioNTech COVID-19 Vaccine Trial Data
The clinical trial data for the Pfizer-BioNTech COVID-19 vaccine contains a glaring anomaly that could potentially invalidate the entire study’s claimed findings.
The clinical trial data for the Pfizer-BioNTech COVID-19 vaccine contains a glaring anomaly that could potentially invalidate the entire study’s claimed findings.
Despite less than three months’ use and far lower numbers of people vaccinated, the new COVID-19 vaccines have triggered up to 96 times more death reports than regular influenza vaccines. The differences are huge – and disturbing.
The Centers for Disease Control and Prevention (CDC) is a powerful agency that influences vaccine policy not just in the US, but around the world. Which is a pity, because it is riddled with corruption and conflicts of interest. The industry-funded CDC’s latest propaganda exploits involve portraying the poorly-tested COVID-19 vaccines as safe and beneficial, and shamelessly brushing off the ever-increasing death toll of these vaccines as pure coincidence. This article explains why the CDC has no credibility on this issue whatsoever.
Despite its hurried approval late last year, we are repeatedly told the Moderna COVID vaccine has been thoroughly tested and proven safe and effective. That’s a lie. The clinical trial research for this drug is woefully incomplete, contains a number of curious anomalies, and shows the vaccine has a far higher rate of side effects. And – as with the Pfizer-BioNtech and Oxford-AstraZeneca vaccine research – it dismally fails to provide even remotely credible evidence that a COVID vaccine can save even a single life.
Moderna is an overpromising, underdelivering company that had previously failed to bring even a single drug to market. Despite this poor track record, it became the first company to get US federal backing for COVID vaccine development. It’s vaccine is based on unproven and potentially dangerous technology, yet was granted “emergency use” authorization in December 2020. Moderna has also become a stock market darling, with a market capitalization that simply cannot be justified by its current revenue prospects.
The new Pfizer-BioNTech COVID-19 vaccine has not been fully tested, uses unproven technology, was prematurely rushed to market under the guise of ’emergency use’ approval, and – to top it all off – is now linked to dozens of otherwise inexplicable deaths around the world.
Copyright © 2024 | WordPress Theme by MH Themes